# Detection of CSF Next Generation Sequencing in the Application of Brain Metastases From Lung Adenocarcinoma or Meningeal Metastasis

> **NCT03029065** · — · UNKNOWN · sponsor: **Shandong Cancer Hospital and Institute** · enrollment: 50 (estimated)

## Conditions studied

- Recruitment

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03029065
- **Lead sponsor:** Shandong Cancer Hospital and Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2018-01
- **Final completion:** 2018-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2017-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03029065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03029065, "Detection of CSF Next Generation Sequencing in the Application of Brain Metastases From Lung Adenocarcinoma or Meningeal Metastasis". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT03029065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*